Skip Ribbon Commands
Skip to main content

Probiotics Task Force

Diet, Health and Disease

Background

Probiotics are of growing interest within the scientific community, for consumers and for the food industry. They potentially provide functional health benefits. The interaction between the gut and intestinal flora and between resident and transient flora defines a new area in physiology, an understanding of which would shed light on the ‘cross talk’ between humans and microbes.
 
Health claims on specific probiotics are accepted in the USA, in Japan, and in some European countries. However, there is a need for comprehensive and harmonised guidelines on the assessment of the characteristics of probiotic as foods, biotherapeutic agents.
 

Objectives

The mission of the task force (TF) is to investigate how the physiological efficacy of probiotics can be assessed and to develop appropriate guidelines and recommendations to move the research field forward.
 
Therefore, the task force aims at advancing the understanding of scientific issues related to functional foods containing probiotics can impact the gut functions and health in general.
 

Impact 

The work of the task force is contributing to the scientific understanding and underpinning of health claims regulations.
 
The evaluation of the range of activities will allow for fair comparison between different strains of probiotics and various products. Regulators will benefit from a guideline on the evaluation of the probiotics-related claims. Ultimately, the scientific substantiation of claimed benefits should increase consumers’ confidence in health claims.
 
A working relationship has been established with the IDF/ISO Joint Action Team (JAT) on Probiotics. The IDF/ISO JAT is represented as observer at the TF meetings in order to ensure coordination of work and communication between the two organisations.
 

Activities 

Probiotics: Interplay with the intestine barrier function
 
The Task Force decided to look at the potential impact of probiotics on the gut microbiota, with an initial focus on the intestine barrier function. A brainstorming meeting with academic experts concluded that intestinal barrier impairment and microbiota changes can be influenced by different risks factors for Irritable Bowel Syndrome (acute infections, antibiotic usage, stress or other dietary factors), inducing a low grade inflammation that can contribute to different comorbidities and to changes in the gut physiology. However, a treatment with appropriate probiotic strains could be able to restore the intestinal barrier function and avoid the related cascade of stress.
 
An expert group is being set up to investigate how probiotics could impact the gut barrier function, differentiating indirect (modulation of the gut microbiota) and direct actions. As a first step, the expert group will look at intestinal barrier function, using both in vitro and animal data. As a second step, additional experts will be contacted to establish the impact of the intestinal barrier dysfunction at the human level.
 
The different outcomes of this activity will be published in a peer-reviewed journal and disseminated through presentations in scientific congresses and through our network with other probiotics associations.
 
Further information is also provided under the section on the transversal activity - Marker Validation Initiative ‘Step 1’.
 
Markers of Immuno-modulation for the General Population
 
It is known that immune markers are modulated within a certain range where it is still considered as safe. The lower and upper limits of this safe range are known for most of the immune markers from medical data. What is not always known is ‘how a certain ingredient can trigger a modulation’ and ‘how detrimental/beneficial this stimulation can be on the consumer’s health’. The Nutrition and Immunity Task Force together with the Probiotics Task Force commissioned an expert group to provide relevant markers and reference values in context of immuno-modulation induced by a dietary intervention within the healthy population.
 
A workshop will be held on 16 and 17 April 2012 with the objectives firstly to invite external experts to review the work done by the group. Secondly, it is aimed to propose scenarios for interpreting results observed during a trial. By this approach, the workshop contributes to a better understanding of the current limitations and insight in emerging opportunities for assessing immune modulation. It will thus promote further consensus on valuable and accessible markers for conducting intervention trials.
 
The outcome will be submitted to a peer-reviewed journal. The publication will summarise the markers reflecting normal function of the immune system which are indicative for immune modulation by nutrients/bio-active ingredients. It will also include proposals for interpreting variations in these markers.
 
Further information is also provided under the section on the transversal activity - Marker Validation Initiative ‘Step 1’.
 
Joint Concise Monograph on Probiotics and Prebiotics
 
Facing the recent published data on probiotics and prebiotics and their impact on health, the task force decided to join forces with the Prebiotics Task Force to commission a Concise Monograph. The aim is to provide the reader with a single document compiling both probiotic and prebiotic concepts that the public often mixes up. It would contain science-based answers to questions on modulating the gut microbiota by dietary intervention with probiotics and prebiotics in a balanced and complementary way.
 

Task Force Collaborators

Members 2012
 
Dr. Arthur Ouwehand - Chair -
DuPont Nutrition Biosciences
FI
Dr. Annick Mercenier - Co-chair -
Nestlé
CH
Dr. Jean-Michel Antoine
Danone
FR
Dr. Stephanie Courau
Merck Consumer Healthcare
FR
Dr Diana Diofebi
Dicofarm
IT
Dr. Udo Herz
Mead Johnson Nutrition
NL
Dr. Irene Lenoir-Wijnkoop
IDF - ILSI Liaison Officer
FR
Dr. Tami Mackle
Pfizer Consumer Healthcare
US
Dr. Barbara Miller
Procter & Gamble
US
Dr. Arjen Nauta
Royal FrieslandCampina
NL
Dr. Tomoyuki Sako
Yakult Europe
NL
Dr. Karl-Heinz Zirzow
Cargill
BE
Ms. Agnès Méheust
ILSI Europe
BE
Ms. Toula Aslanidis
ILSI Europe
BE
 
 
Probiotics: Interplay with the intestine barrier function
 
Prof. Jerry Wells - Chair -
Wageningen University
NL
Prof. Robert Brummer
Örebro University
SE
Prof. Patrice Cani
Université catholique de Louvain
BE
Dr. Jan Dekker
Wageningen University
NL
Dr. Muriel Derrien
Danone
FR
Prof. Willem de Vos
Wageningen University
NL
Dr. Clara Garcia
Nestlé
CH
​Prof. Thomas Mac Donald Centre for Immunology and Infectious Disease​ UK​
Dr. Arjen Nauta
Royal FrieslandCampina
NL
Dr. Vassilia Theodorou
National Institute of Agricultural Research - INRA
FR
Dr. Freddy Troost
Maastricht University
NL
Ms. Agnès Méheust
ILSI Europe
BE
 
 
Expert Group on Markers of Immuno-modulation for the General Population
 
Prof. Ulrich Sack - Chair -
Universität Leipzig
DE
Dr. Phoukham Phothirath - Co-chair-
Nestlé
CH
Dr. Ruud Albers
NutriLeads BV
NL
Dr. Raphaëlle Bourdet-Sicard
Danone
FR
Prof. Philip Calder
University of Southampton
UK
​Dr. Murielle Cazaubiel ​Institut Mérieux ​FR
Dr. Udo Herz
Mead Johnson Nutrition
NL
Prof. Claude Lambert
University HospitalCentre Hospitalier Universitaire St. Etienne
FR
Dr. Irene Lenoir-Wijnkoop
IDF - ILSI Liaison Officer
FR
Prof. Jean-François Nicolas
Centre Hospitalier Universitaire Lyon-Sud
FR
Dr. Arthur Ouwehand
DuPont Nutrition Biosciences
FI
Dr. Tomoyuki Sako
Yakult Europe
NL
Prof. Seppo Salminen
University of Turku
FI
Dr. André Siemensma
Royal FrieslandCampina
NL
Prof. Henk van Loveren
National Institute of Public Health and the Environment – RIVM
NL
Ms. Agnès Méheust
ILSI Europe
BE
Ms. Marie Latulippe
ILSI Europe
BE
 
Joint Concise Monograph on Probiotics and Prebiotics
Author
 
 
Dr. Nino Binns
Consultant
IE
Scientific Editors
 
 
Prof. Glenn Gibson
University of Reading
UK
Dr. Mary-Ellen Sanders
International Scientific Association for Pro & Prebiotics
US
Scientific Reviewers
 
 
Prof. Nathalie Delzenne
Université Catholique de Louvain
BE
Prof. Lorenzo Morelli
Catholic University of Piacenza
IT
 

Publication

J. Neu, Guest Editor. Guidance for Assessing the Probiotics Beneficial Effects: How to Fill the GAP. The Journal of Nutrition 2010;140:S671-S721.
 
To download the poster on Exploring the Interactions between Probiotics and Health, please click here .
 
For more information, please contact info@ilsieurope.be.

 

Probiotics Task Force